Semaglutide may cause nausea in a few ways, including by slowing gastric emptying, activating GLP-1 receptors, and making you feel overfull or bloated
If you wish to switch from weight loss injections to orforglipron (Foundayo), you need to do so under clinical supervision
They are commonly used in provider-guided wellness protocols designed to support balanced eating habits, metabolic efficiency, and overall routine consistency
But retatrutide is still investigational, which means it cant be prescribed outside clinical trials
You're not alone, and it's a very common experience
However, those taking the higher dose lost even more weight, 13.2% on average